EUDA Health (EUDA) Competitors

$1.96
+0.14 (+7.69%)
(As of 04/26/2024 ET)

EUDA vs. NOVV, HHGC, PPHP, ATPC, UPHL, PIII, DXR, CDTX, JAGX, and NSPR

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Nova Vision Acquisition (NOVV), HHG Capital (HHGC), PHP Ventures Acquisition (PPHP), Agape ATP (ATPC), UpHealth (UPHL), P3 Health Partners (PIII), Daxor (DXR), Cidara Therapeutics (CDTX), Jaguar Health (JAGX), and InspireMD (NSPR).

EUDA Health vs.

Nova Vision Acquisition (NASDAQ:NOVV) and EUDA Health (NASDAQ:EUDA) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Nova Vision Acquisition has higher earnings, but lower revenue than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nova Vision AcquisitionN/AN/A$150K$0.04296.32
EUDA Health$9.84M4.91-$24.88MN/AN/A

37.4% of Nova Vision Acquisition shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. 43.3% of Nova Vision Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nova Vision Acquisition's return on equity of 0.00% beat EUDA Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Nova Vision AcquisitionN/A -6.23% 0.79%
EUDA Health N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nova Vision Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Nova Vision Acquisition and EUDA Health both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Nova Vision AcquisitionN/AN/A
EUDA HealthN/AN/A

In the previous week, Nova Vision Acquisition and Nova Vision Acquisition both had 1 articles in the media. EUDA Health's average media sentiment score of -1.00 equaled Nova Vision Acquisition'saverage media sentiment score.

Company Overall Sentiment
Nova Vision Acquisition Negative
EUDA Health Negative

Summary

Nova Vision Acquisition beats EUDA Health on 4 of the 6 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$48.28M$818.56M$4.87B$7.55B
Dividend YieldN/A1.75%2.91%3.95%
P/E RatioN/A34.92224.0518.60
Price / Sales4.912.172,335.5285.76
Price / CashN/A19.1846.8534.73
Price / Book-11.532.174.754.33
Net Income-$24.88M-$15.00M$103.38M$214.22M
7 Day Performance12.00%-0.18%0.74%1.88%
1 Month Performance8.89%-7.99%-7.58%-5.23%
1 Year Performance18.79%3.08%9.21%8.41%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOVV
Nova Vision Acquisition
0 of 5 stars
$11.85
-0.3%
N/A+9.5%$39.34MN/A296.322,021Short Interest ↑
HHGC
HHG Capital
0 of 5 stars
$11.30
+0.1%
N/A+7.6%$57.07MN/A161.432,021Positive News
PPHP
PHP Ventures Acquisition
0 of 5 stars
$11.07
flat
N/AN/A$28.75MN/A-27.672,021
ATPC
Agape ATP
0 of 5 stars
$0.25
flat
N/AN/A$19.20M$1.43M-12.4821Gap Down
UPHL
UpHealth
0 of 5 stars
$0.84
-9.7%
N/AN/A$15.73M$130M-0.26374
PIII
P3 Health Partners
1.3283 of 5 stars
$0.51
-1.9%
$4.75
+825.9%
-63.7%$162.06M$1.27B-0.79400Positive News
DXR
Daxor
0 of 5 stars
$9.80
+0.1%
N/AN/A$46.45MN/A0.00N/AShort Interest ↑
Negative News
CDTX
Cidara Therapeutics
4.4235 of 5 stars
$0.51
flat
$4.67
+810.6%
-39.3%$46.44M$64.29M-1.3173Analyst Report
Stock Split
Short Interest ↓
Analyst Revision
News Coverage
Gap Down
High Trading Volume
JAGX
Jaguar Health
0 of 5 stars
$0.17
-5.6%
N/A-65.4%$46.41M$9.76M0.0049Short Interest ↓
NSPR
InspireMD
2.0718 of 5 stars
$1.98
+3.7%
$4.85
+145.6%
+90.5%$46.22M$6.21M-1.8365Analyst Report
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:EUDA) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners